Abstract
Intervention analysis of introduction of rotavirus vaccine on hospital admissions rates due to acute diarrhea Análise de intervenção da introdução da vacina do rotavirus nas taxas de internação hospitalar por diarreia aguda Análisis de intervención en la introducción de la vacuna contra el rotavirus en las tasas de hospitalización por diarrea aguda Introduction Diarrhea is the second leading cause of death among children under 5 years old in the world, affecting approximately 1.5 million children per year. Currently, 39% of children with diarrhea in developing countries receive the recommended treatment, and limited data until now suggests some progress since 2000 1 .
Worldwide, rotavirus is considered one of the most important agents of gastroenteritis and death in children under 5 years old. It is estimated that every year there are 125 million diarrhea cases associated with rotavirus, resulting in 418,000 to 520,000 deaths, 85% of which are in less-developed regions. These data reflect 20% of global mortality by diarrheal disease and 5% of the total of deaths of children younger than 5 years old 2 .
In Brazil, the oral vaccine of human rotavirus (VORH) was included in National Program of Immunization (PNI) in March 2006, resulting in less severe intestinal diseases in children less than 5 years of age; we observed effects on infant mortality 3 . According to the Brazilian Ministry of Health, the diarrhea incidence associated with rotavirus varies between 12% and 42% based on estimates that approximately 2,500 children younger than 5 years old died per year before the introduction of the vaccine.
Clinical tests of VORH demonstrated that for the first year of life, there was an effective protection of 87.1% against any gastroenteritis caused by rotavirus, of 95.8% against acute gastroenteritis caused by rotavirus, and of 91.8% against gastroenteritis caused by rotavirus demanding medical assistance; finally, VORH prevented 100% of hospitalizations due to gastroenteritis by rotavirus 4, 5 . These studies detected a 29% reduction in hospitalizations due to acute diarrhea in children younger than 1 year old, making necessary vaccination coverage equal or higher than 95% 2 .
After the introduction of VORH in many countries, the reduction in hospitalization rates (HRs) was verified as it was in Brazil. Published studies indicating the reduction of HRs due to acute diarrhea in Brazil noticed a decline for children until 24 months, with a 48% reduction for the year 2007 when compared with the pre-vaccination period 6 . However, for Southern regions, there was no significant decline in HRs. Other evaluations, with a longer period of use of the VORH through 2009 7 8 .
With regards to the methodology, Lanziere et al. 6 used descriptive analysis and Carmo et al. 7 applied regression methods. No studies were found of the vaccine effect using specific methods for time series modeling. In this sense, this paper examines the effect of the VORH on HRs due to acute diarrhea using a time series investigation with analysis of intervention by Box-Jenkins methodology.
Intervention time series (ITS) analysis models the effect of an external and known intervention on data such as counts of events collected regularly in time. Such data or time series often show serial dependence in which observations are correlated with previous ones (one or more months, in the case of seasonal effects). Appropriate methods for handling such data enable some interventions to be modeled and their effect can be estimated after adjusting for serial dependence, trends, and seasonal effects, by using linear models to quantify increases or decreases in the mean level or slope of the series. ITS analysis tests the causal hypothesis that the mean level or slope of the time-series is different after the intervention, or seeks to estimate the magnitude of intervention effects.
ITS is typically conducted with the Box & Jenkins Auto-regressive Integrated Moving Average -ARIMA (http://stats.stackexchange.com/tags/ arima/info) framework, using the methods outlined by Box & Tiao 10 . However, other methods such as segmented regression may be used. These 2 time series methods, adequately applied, enable the effect of the event to be separated from general trends and serial dependencies in time, thereby enabling valid statistical inferences to be made about whether an intervention has had an effect on a time series. Ramsay et al. 11 emphasized the necessity of correct modeling and analysis of interrupted time series. The paper showed that many ITS studies in the literature had analytical shortfalls. Thus, these considerations justify the importance of the application of this methodology, which is briefly described in the next section.
Methodology
Descriptive-analytical observational study of monthly hospitalization rates due to acute diar-rhea in children younger than 5 The available data in the electronic address of the DATASUS (www.datasus.gov.br) were obtained from the System of Hospital Information of SUS (SIH-SUS) by using the 10th revision of the International Classification of Diseases (CID-10) with the codes A00 and A09.
The age groups included younger than 1 year old (until 11 months and 29 days), 1 year old (older than or equal to 12 months to 23 months and 29 days), 2 years old (older than or equal to 24 months to 35 months and 29 days), 3 years old (older than or equal to 36 months to 47 months and 29 days) and 4 years old (older than or equal to 48 months to 59 months and 29 days). The calculation of the HR due to acute diarrhea was performed by dividing the number of hospitalizations due to acute diarrhea by the population of each age group and multiplying the coefficient per 10,000. The values of the population used in the rate calculus from 1 to 4 years old groups were the Brazilian Institute of Geography and Statistics (IBGE) census in the years 2000 and 2010; the inter census estimates were used from IBGE for the remaining years. For the age group younger than 1 year old, the values of the population were obtained from Information System on Live Births (SINASC).
The data were processed in Tabwin program (DATASUS. http://portal.saude.gov.br/portal/ se/datasus/area.cfm?id_area=732), Excel (Microsoft Corp., USA), and R program (The R Foundation for Statistical Computing, Vienna, Austria; http://www.r-project.org). In R program, the packages t-series, and TSA (Times Series Analyses) were used to implement the methodology.
First, a descriptive analysis was performed for each age group and the monthly HR time series were analyzed for the 22 regional health divisions of Paraná State.
For the time series modeling with ITS analysis, the identification, estimation, and validation of the models considering the Box & Jenkins Seasonal ARIMA (SARIMA) methodology was applied for all HR time series. The choice of SARIMA models is due to the fact some series present seasonal characteristics. The general model for a time series Y t is given by where N t represents the time series before the intervention modeled by a SARIMA process 10, 11 m t and is the change in the mean function due to the intervention. Before the intervention, m t is assumed to be zero. To specify m t , a function such as a pulse or step is useful 9 . Pulse interventions refer to temporary effects (only a limited number of time periods), whereas step interventions lead to a permanent change in the time series, which is the case under study. Both functions can be represented by a binary or dummy variable, and in the case of a pulse intervention, it takes the value of 1 only for the time period when the intervention occurs. In the case of a step intervention, it takes a value of 1 starting in the time period when the intervention occurs as well as in all time periods thereafter.
The increases or decreases in the slope of the time series after the event can be estimated from the data by applying transfer functions 11 to this step function. These transfer functions modify simple step or pulse functions to represent a range of possible effects or changes that may occur after a period of intervention. Thus, the estimated parameter of most interest is the slope post-intervention. Furthermore, the effect of the intervention on time series can be projected for the actual time by multiplying the slope by the number of observations during the period post-intervention.
In relation to N t in equation (1), before identification of the best-fitting model N t , the time series must be transformed, if necessary, into one that is stationary, which means that the mean and the auto-covariance do not depend on time. Roughly speaking, the mean and the variance are constant in the time series period. The stationarity can be induced through first or second differencing, or through a Box-Cox transformation 12 . There are several ways to check for non-stationarity, including plotting the data to inspect visually for shifts in the series, observing a slow decay of the autocorrelation (ACF), or performing the Dickey-Fuller test for stationarity.
When the time series shows stable behavior over the entire period of the study (outside of the period due to the intervention), SARIMA models can be fit directly to the data series or to a series that has been treated to induce stationarity 12 . To identify the best-fitting SARIMA models considering the serial dependences, the ACF and partial auto-correlation function (PACF) for the stationary series are compared with the ACF and PACF of theoretical models 12, 13 .
In the estimation step, the data are used to estimate the parameters of the chosen model for N t , by the maximum likelihood method. Once the parameters are estimated, the validity of the estimated model is checked. Normality tests of the residuals are applied. ACF and Portmanteau BoxPierce test can be applied on the residuals from the estimated model to verify that the residuals are uncorrelated, which confirms that the estimated model captures most the information the series could provide.
It is possible that more than one model will be identified. In this case, the number of significant terms or parsimony, smallest corrected Akaike Information Criterion (AICc), and prediction variance are relied on to select the final model 12 .
Details of the ARMA and SARIMA models as well as ITS analysis are given in Box et al. 12 and Cryer & Chan 14 .
The 
Results
From 2000 until 2011, 108,298 hospitalizations were registered in Paraná State according to the classification of ICD-10, codes A00-A09, for a population of 10,261,004 children under 5 years old. The average HRs varied from 118.09 to 65.09/10,000 during the study period. The average and standard deviations for HRs according to the year and group age are presented in Table  1 . The largest average reached was 250.36 in 2000 for children younger than 1 year old.
The average by year considering all age groups was 104.47 for 10,000 children. The absolute standard deviations before the VORH were smaller than after the VORH, e.g., 142.18 versus 74.59 for the children younger than 1 year old. On the other hand, as the averages were drastically reduced, the relative standard deviations should be observed by the variation coefficient (standard deviation divided by the average). Thus, it is possible to note that before the VORH, the variation ranged from 48% to 55%, while after the VORH, the variation coefficients were almost the same, ranging from 45% to 50%, representing the heterogeneity of the HRs. The age group composed of children younger than 1 year old represented 30.64% of hospitalizations; the age group of 1-year-old children, 30.52%; the 2-year-old group, 17.95%; the 3-year-old group, 11.81%; and the age group with the lowest rate of hospitalization was the 4-year-old group, with 9.07%.
After
Once the models were estimated and validated, the adjusted models (gray line) were plotted in relation to the original series (black line) for each age group. In Figures 1 and 2 , one can see the graphics for the younger than 1 year old and 1-year-old groups, respectively. The dashed line is the average level for the period before the vaccine (2000) (2001) (2002) (2003) (2004) (2005) .
In Figure 1 , one can note that the adjusted model for most of the HR time series of children younger than 1 year old shows a decrease. However, for health region 18, a clear increase can be noted. The quantification of the decreases or increases was evaluated by the estimated slope parameter. This parameter indicates the reduction by month per 10,000 children. This effect of reduction is better understood when projected at the end of the analyzed period (December 2011). The projected effects are presented in Table 2. When the slope estimated parameter was not statistically significant, the projected effect was represented by zero. For children younger than 1 year old, considering each regional division specifically, there were reductions in HRs in 11 regional divisions (1, 7, 9 10, 12, 13, 14, 15, 16, 20 , and 22) with 12-32 reduced cases/month per 10,000 hospitalizations, 4 regional divisions (3, 15, 19, and 21) with no statistically significant decrease, and 1 regional division with a statistically significant increase of 6 cases/month/10,000. The average reduction by regional division in this age group was 11 cases/month/10,000 (Table 2). By analyzing the percentage reduction of the HRs in December 2011 in relation to the average level of cases before the vaccine, this age group presented an average reduction of 47% by regional division (Table 2) .
For 1-year-old children, the adjusted model also shows a statistically significant decrease in the HRs for most regional divisions accompanying the original series (Figure 2 ). In the evaluation of the 1-year-old age group, 13 regional divisions presented reductions of 12 to 32 hospitalizations/month/10,000. Regional divisions 18 and 21 also did not have statistically significant decreases for this age group, and regional division 2, which had a slight decrease for children younger than 1 year, did not have a decrease in the HR for the one-year-old group. It was also verified that the average percentage reduction of HRs by regional division was 58% (Table 2 ).
In the time series for the age groups of 2-and 3-year-old children, when the decrease occurred, it was less dramatic, with reductions of up to 19 cases/month/10,000 hospitalizations. Most regional divisions had no statistically significant reduction (p > 0.05) ( Table 2 ). For these age groups, the average percentage reduction of HRs in December 2011 in relation to the average level before the vaccine was 21% and 7%, respectively (Table 2 ). In the 4-year-old age group, most regional divisions had no statistically significant reduction in HR, and, in fact, slight increases were verified in 5 regional divisions.
When the average pre-vaccination level (65 cases/month/10,000) of the HRs by regional division is compared with the post-vaccination period in December 2011 (36 cases/month/10,000), an average decrease of 29 cases/month/10,000 is observed. The largest decrease was for regional division 13 (100 cases/month/10,000). On the other hand, regional divisions 18 and 21 had increases of 8 and 4 cases/month/10,000 hospitalizations after the introduction of the VORH, respectively.
Discussion
For the study period 2000 to 2011, hospitalization rates for acute diarrhea confirm the magnitude of diarrheal disease on the health of children less than 5 years of age and the importance of programs aimed at reducing these rates, such as the rotavirus vaccine.
Considering the descriptive analysis in Table 1 , a higher HR was observed in the pre-vaccination period for children younger than 1 year old (256 on average) and a lower HR for the 4-year-old age group (60 on average). After VORH introduction, these average rates decreased to 96 and 38 in 2011, respectively. Even with this reduction, rates above these averages were encountered in national and international literature. From a literature search of worldwide studies from 1986 to 2000, the rate of hospitalizations due to acute diarrhea in children younger than 1 year old was found to be 71.25 cases per 10,000, and for children from 1 to 4 years old, the HR was 18.90 cases per 10,000, highlighting the severity of diarrheal disease in small children until 2 years old, as most children in the later age range already have antibodies against rotavirus 14 .
If all age groups are considered, the average HR by month was 154.75 before the vaccine and 122.32/10,000 after. The HR was calculated by considering the entire population, although it is known that 24.5% of the population of the country has private health insurance and the hospitalization of these patients was not part of the database 15 . The great variation in HRs among the regional divisions from 2000 to 2011 is remarkable, ranging from 35.30 to 344.55/10,000 hospitaliza- tions for regional divisions 2 and 7, respectively. This variation in HRs is also evident observing the standard deviations in Table 1 .
By ITS analysis, a higher reduction in the HR for children younger than 1 year old (21 cases/ month/10,000 on average by regional division) and a lower reduction in the HR for the age group of 4-year-old children (5 cases/month/10,000 on average by regional division) with decreases to 9 and 4 cases/month/10,000 in the end of 2011, respectively, was noted in the present study. Cases were reduced by an average of 29 cases/month by regional division.
Furthermore, by ITS analysis, it was observed that for children younger than or equal to 1 year old in all Paraná regional health divisions, 467 hospitalizations/month/10,000 were avoided, and for the other age groups, the reduction was small (93 cases/month), considering the projected effect in December 2011. In a study performed across It is important to highlight, as we can see in Figures 1 and 2 , that the incidence of diarrhea has been decreasing for some regions since 2000, and the autoregressive characteristics of the SARIMA modeling in ITS analysis took this into account.
Furthermore, the adjustment underestimates the observed time series, as expected, due to the model structure. However, for some time series, the estimation was poor because the time series presented a random behavior, e.g., region 20 in Figure 2 .
Although it was verified by ITS analysis that children younger than or equal to 1 year old were the most benefited with vaccination, other actions contribute to acute diarrhea prevention, such as incentivizing breastfeeding and better quality of primary attendance. These factors may be interfering in these values and may not be implemented homogeneously in all regional divisions, making necessary the improvement of more efficient strategies to support the municipalities and influence the management of regional issues to foment the continuous and growing search for efficiency with quality.
The variations in HRs due to acute diarrhea in regional health divisions, even after the introduction of VORH, can be noted by the standard deviations in Table 1 . This fact suggests a subordination of the data, weakening the usefulness of hospitalization rates as an indicator of morbidity, as some regional divisions may not have appropriate data quality, resulting in under-reporting of diarrheal disease. The system of notification does not identify the individual or multiple hospitalizations due to the same problem, which leads to an overestimation of the health problem and prevents the evaluation of re-hospitalization and transfers 15 . Although it could help in the evaluation of prevention measures for acute diarrhea, records completed during hospitalization for the treatment of infectious diarrhea exclude the identified etiology, not excluding case studies that detected factors that lead children younger than 5 years old to hospitalization.
This great variation can also indicate that rotavirus outbreaks still happen and reach the population of children younger than 1 year old who received only the first dose of the vaccine. In Australia, a retrospective case-control study determined that the efficiency of the vaccine to protect against hospitalization during rotavirus outbreaks in native children was 57.1% with 1 dose of the vaccine and 84.5% with 2 doses 16 .
Another factor that may be influencing the hospitalization rates is the rotavirus vaccination coverage in Paraná State. In the present study, the vaccination coverage in 2006 was 50.13%; this may be due to the irregular provision of vaccine to the health units. This year was also one with the highest dropout rate, where 34.02% of the children who had the first dose did not complete the basic plan of 2 doses. It is important to observe that this vaccine has different characteristics of other vaccines that allow the vaccination regimen to be completed at any age in children. (Table 1) . During the six years of vaccination coverage, there was a large percentage of unimmunized children, which is a concern because it is not yet known what will be the behavior of the natural disease for children over 2 years of age who have not received the vaccine.
In countries with VORH included in their basic calendar, as in the USA, it was verified in 2007 that after a year of the vaccine's use, with 49% vaccination coverage for the first dose, that the hospitalization rate due to acute diarrhea decreased by 16%, and in the following year, with slightly more than a third of the children completing the vaccine schedule of 3 doses (pentavalent vaccine), the reduction was by 45% 18 . In El Salvador, it was noted that children younger than 2 years old with 2 doses of the vaccine (monovalent vaccine) had a 76% reduction in HRs due to rotavirus and a 51% reduction with 1 dose. In these studies, even with lower than recommended vaccination coverage, a significant reduction in the hospitalizations due to acute diarrhea was found 19 , which suggests that VORH has an indirect protective effect, noting that in these studies there was the identification of the agent that led to hospitalization.
The identification of the acute diarrheal agent is necessary to evaluate the efficiency of the vaccine through the years because in clinical trials, the vaccine used in Brazil demonstrated efficiency against gastroenteritis caused by rotavirus G1P [8] , G2P [4] , G3P [8] , G4P [8] and G9P [8] 4, 5 . Before the introduction of the vaccine, type G1P [8] was the most prevalent. In 2006, a rotavirus outbreak in Northeast Brazil had 780 cases, of which 100% of the 15 patients who were hospitalized were found to be positive for G2[P4] 20 . In São Paulo, it was identified that the predominant serotype was G2 21 .
The evaluation of the effect of the vaccine is complex as the decrease of HRs was also observed before the introduction of the VORH and important variations in these rates were noted even after the introduction of the vaccine, as was the case in 2008 when there was an increase in HRs in this study and others for the entire country 6, 7 . Further, Brazil has not identified the diarrheal agent that led to the hospitalization of these children. Additionally, great regional differences in HRs in Paraná state were observed with similar results in other studies that evaluated all the hospitalizations in the country by region. Thus, studies that consider only data from sentinel hospitals for the disease may not demonstrate the effect of VORH on hospitalization rates.
Conclusion
This study concluded that hospitalization rates due to acute diarrhea, following a national trend, is decreasing in almost all regional health divisions of Paraná State, as was observed from 2006 to 2011. Despite the discussed limitations related to the data, from the ITS analysis with Box-Jenkins methodology, the effect of the introduction of VORH on the HRs due to acute diarrhea could be estimated.
The reduction in HRs in some regional divisions may be related to general measures of diarrheal disease prevention, the hospitalization registers or better rates of vaccination coverage. It is still necessary to have a national network for systematic epidemiological vigilance with the identification of cases of rotavirus hospitalization, as this strategy would ease the monitoring of vaccine efficiency and the disease behavior with circulation of serotypes that are not integrated in the vaccine composition due to the large antigenic diversity responsible for the multiplicity of serotypes, which may make their control difficult.
With the introduction of the vaccine, children younger than or equal to 1 year old presented more significant decreases in HRs. It is important to remember that the highest HRs are in this age group, which highlights the disease severity in small children, making necessary the need to discuss the causes of acute diarrhea in this age group and develop strategies for its reduction. As it was observed that there was no decrease for 3-and 4-year-old children, continuous monitoring will indicate whether the disease incidence for these age groups will decrease.
The reduction of the HRs was effective, but the continuous monitoring for a reduction in cases of acute diarrhea cannot be discarded, as these cases may be related to other factors beyond the vaccine. The evaluation of other interventions such as sanitation, breastfeeding, nutrition, oral rehydration and access to health care are also important factors to be studied.
Finally, most of the time series analyzed presented an annual seasonal effect. This finding reinforces the importance of considering aggregating the estimation of SARIMA models and ITS analysis and indicates the necessity for more investigations related to the seasonal behavior, which may be associated with climate factors. 
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